Product Dossier
APO-DESVENLAFAXINE MR
Product Dossier for APO-DESVENLAFAXINE MR (desvenlafaxine benzoate, Arrotex Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes — compiled by…
- Sponsor: Arrotex Pharmaceuticals
- Active ingredient: desvenlafaxine benzoate
- Therapeutic area: Psychiatry
- Same area: INVEGA
- Same area: NICABATE
What it is
APO-DESVENLAFAXINE MR is an extended release tablet containing desvenlafaxine (as benzoate).
Regulatory history
APO-DESVENLAFAXINE MR was first registered on the ARTG on 12 November 2014 in two strengths: 50 mg and 100 mg extended release tablets.